Skip to content
Disclosery

Ballentine Partners, LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Ballentine Partners, LLC on GSK, newest first. How the timeline and the estimate are built.

Ballentine Partners, LLC held 22,415 GSK shares at 2026-06-30 per its 13F-HR filed 2026-07-17.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 22,415 shares
    Change vs previous 13F +2,325 shares

    0.01% of the 13F portfolio, value $1,174,995.

    13F-HR 0001172661-26-002674 filed by Ballentine Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 20,090 shares
    Change vs previous 13F +1,945 shares

    0.02% of the 13F portfolio, value $1,108,767.

    13F-HR 0001172661-26-001909 filed by Ballentine Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 18,145 shares
    Change vs previous 13F -1,341 shares

    0.01% of the 13F portfolio, value $889,831.

    13F-HR 0001172661-26-000457 filed by Ballentine Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 19,486 shares
    Change vs previous 13F -255 shares

    0.01% of the 13F portfolio, value $841,015.

    13F-HR 0001172661-25-004541 filed by Ballentine Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 19,741 shares
    Change vs previous 13F -465 shares

    0.01% of the 13F portfolio, value $758,055.

    13F-HR 0001172661-25-002596 filed by Ballentine Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 20,206 shares
    Change vs previous 13F +3,056 shares

    0.01% of the 13F portfolio, value $782,780.

    13F-HR 0001172661-25-001551 filed by Ballentine Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 17,150 shares
    Change vs previous 13F +4,959 shares

    0.01% of the 13F portfolio, value $580,013.

    13F-HR 0001172661-25-000227 filed by Ballentine Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 12,191 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $498,369.

    13F-HR 0001172661-24-004333 filed by Ballentine Partners, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).